Cancer in older adults: Understanding cause and effects of chemotherapy-related toxicities

Vijaya R. Bhatt

doi:10.2217/fon-2019-0159

Cancer in older adults: Understanding cause and effects of chemotherapy-related toxicities

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	2557-2560
Number of pages	4
Journal	Future Oncology
Volume	15
Issue number	22
DOIs	https://doi.org/10.2217/fon-2019-0159
State	Published - Aug 2019

Keywords

cancer treatment
older adults
toxicities

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.2217/fon-2019-0159

Cite this

@article{aabe2f2bf35c45659cf2475d274c7554,

title = "Cancer in older adults: Understanding cause and effects of chemotherapy-related toxicities",

keywords = "cancer treatment, older adults, toxicities",

author = "Bhatt, {Vijaya R.}",

note = "Funding Information: This work was supported by the National Institute of General Medical Sciences, 1 U54 GM115458, which funds the Great Plains Institutional Development Award (IDeA) Clinical Translational Research (CTR) Network, and the Fred and Pamela Buffett Cancer Center Support Grant from the National Cancer Institute (P30 CA036727). The content is solely the responsibility of the author and does not necessarily represent the official views of the NIH. VR Bhatt reports receiving consulting fees from Pfizer, CSL Behring, Agios, Incyte, Partner Therapeutics and Abbvie, and research funding from Incyte, Tolero Pharmaceuticals, Inc, and National Marrow Donor Program. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript. Funding Information: This work was supported by the National Institute of General Medical Sciences, 1 U54 GM115458, which funds the Great Plains Institutional Development Award (IDeA) Clinical Translational Research (CTR) Network, and the Fred and Pamela Buffett Cancer Center Support Grant from the National Cancer Institute (P30 CA036727). The content is solely the responsibility of the author and does not necessarily represent the official views of the NIH. VR Bhatt reports receiving consulting fees from Pfizer, CSL Behring, Agios, Incyte, Partner Therapeutics and Abbvie, and research funding from Incyte, Tolero Pharmaceuticals, Inc, and National Marrow Donor Program. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.",

year = "2019",

month = aug,

doi = "10.2217/fon-2019-0159",

language = "English (US)",

volume = "15",

pages = "2557--2560",

journal = "Future Oncology",

issn = "1479-6694",

publisher = "Future Medicine Ltd.",

number = "22",

}

TY - JOUR

T1 - Cancer in older adults

T2 - Understanding cause and effects of chemotherapy-related toxicities

AU - Bhatt, Vijaya R.

N1 - Funding Information: This work was supported by the National Institute of General Medical Sciences, 1 U54 GM115458, which funds the Great Plains Institutional Development Award (IDeA) Clinical Translational Research (CTR) Network, and the Fred and Pamela Buffett Cancer Center Support Grant from the National Cancer Institute (P30 CA036727). The content is solely the responsibility of the author and does not necessarily represent the official views of the NIH. VR Bhatt reports receiving consulting fees from Pfizer, CSL Behring, Agios, Incyte, Partner Therapeutics and Abbvie, and research funding from Incyte, Tolero Pharmaceuticals, Inc, and National Marrow Donor Program. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript. Funding Information: This work was supported by the National Institute of General Medical Sciences, 1 U54 GM115458, which funds the Great Plains Institutional Development Award (IDeA) Clinical Translational Research (CTR) Network, and the Fred and Pamela Buffett Cancer Center Support Grant from the National Cancer Institute (P30 CA036727). The content is solely the responsibility of the author and does not necessarily represent the official views of the NIH. VR Bhatt reports receiving consulting fees from Pfizer, CSL Behring, Agios, Incyte, Partner Therapeutics and Abbvie, and research funding from Incyte, Tolero Pharmaceuticals, Inc, and National Marrow Donor Program. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

PY - 2019/8

Y1 - 2019/8

KW - cancer treatment

KW - older adults

KW - toxicities

UR - http://www.scopus.com/inward/record.url?scp=85070818484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070818484&partnerID=8YFLogxK

U2 - 10.2217/fon-2019-0159

DO - 10.2217/fon-2019-0159

M3 - Review article

C2 - 31339058

AN - SCOPUS:85070818484

VL - 15

SP - 2557

EP - 2560

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 22

ER -

Cancer in older adults: Understanding cause and effects of chemotherapy-related toxicities

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this